UCLA scientists have developed advanced miniature 3D tumor organoid models that make it possible to study glioblastoma tumors ...

The pharmaceutical company is running investigational new drug experiments, studies required by the FDA to demonstrate the ...

Decoding the complex communication system of the deadliest brain cancer has revealed that an already approved HIV drug could ...

Two Georgetown University Medical Center oncology professors published a new method for treating a lethal brain tumor in a Jan. 7 paper. Dr. Nagi G. Ayad and Dr. Robert K. Suter led a team of 26 ...

At study entry, patients demonstrated immune compromise consistent with prior standard of care, including radiation and alkylating chemotherapy. The baseline mean absolute lymphocyte count (ALC) was ...

Rising incidence rates, high recurrence, and limited curative options are accelerating demand for innovative glioblastoma ...

Key market opportunities in the glioblastoma multiforme treatment market include increasing demand due to an aging population ...

The Global Glioma Market is focused on managing gliomas, aggressive brain tumors from glial cells. Glioblastoma Multiforme (GBM) is the deadliest type, characterized by rapid growth and invasiveness.

Kyle Donahue, who was given months to live after receiving a diagnosis of glioblastoma in 2021, enrolled in a clinical trial ...

The trial used CAN-3110, an engineered herpes virus, to target and kill glioblastoma tumor cells. CURE sat down with Dr. E.

Glioblastoma is the most aggressive and lethal form of primary brain cancer in adults. Experts explain why it spreads so ...

At study entry, patients demonstrated immune compromise consistent with prior standard of care, including radiation and ...